𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression, of the thrombospondin receptor (CD36) on the cell surface in megakaryoblastic and promegakaryocytic leukemias: Increment of the receptor by megakaryocyte differentiation in vitro

✍ Scribed by Dr. Nobutaka Imamura; Hiromi Ota; Kazuhiro Abe; Atsushi Kuramoto


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
308 KB
Volume
45
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


In this report we describe four cases of acute megakaryocytic leukemia demonstrated by the presence of megakaryocyteplatelet-related cell-surface antigens. These were detected utilizing flow cytometry and monoclonal antibodies In addition to both platelet peroxldase activity, which was shown by ultrastractural cytochemistry, and emergence of differentiation antigens, while culturing these leukemic cells. The blasts of one patient possessed both platelet Gplb and Gpllb/llla cell-surface antigens detected by AN51(CD42b), J15, P2, and HPL2(CD41), respectively, whereas the remainlng three patients almost completely lacked Gplb cell-surface antigen. Hence the former were diagnosed as immature(pro)megakaryocylic leukemla and the latter as acute megakaryoblastic leukemia from the viewpoint of immunophenotyplc analysis. While we cultured these leukemic cells In conditioned medlum prepared from phytohemagglutinln-stimulated leukocytes and interleukln 3, expression of CD36(OKM5) antigen (thrombospondin receptor) increased gradually according to the differentiation and maturation of these cells. Finally, all leukemic cells differentiated to mature megakaryocytes. The function of CD36 on these cells remains to be elucidated.


πŸ“œ SIMILAR VOLUMES


Cell surface expression of TNFRI in tumo
✍ Ian Todd; Patrick Tighe; Susana Rebelo; Richard Powell πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 39 KB πŸ‘ 2 views

evidence that adequate antibiotic therapy eventually eradicates Borrelia even from poorly accessible sites such as synovium. Paradoxically, in the recent Infectious Diseases Society of America guidelines on the treatment of Lyme disease (2), a single-dose antibiotic strategy for preventing Lyme dise